Clinical Trial Update: Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two fixed-dose ARB/HCTZ combinations in adults with mild-to-moderate hypertension has completed, evaluating whether irbesartan/hydrochlo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AVALIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)
• Diovan HCT (valsartan/hydrochlorothiazide)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED